Vector Control
Showing 1 - 25 of >10,000
Malaria Trial (In2Care EaveTube)
Not yet recruiting
- Malaria
- In2Care EaveTube
- (no location specified)
Feb 24, 2023
Dengue Trial in Singapore (Serious game, Dengue prevention website)
Completed
- Dengue
- Serious game
- Dengue prevention website
-
Singapore, SingaporeSingHealth Polyclinics - Sengkang
Mar 29, 2022
Malaria Trial in Bamako (Transfluthrin, Placebo)
Active, not recruiting
- Malaria
- Transfluthrin
- Placebo
-
Bamako, Mali
- +1 more
Apr 29, 2022
Onchocerciasis, Epilepsy Trial in Juba (bi-annual CDTI)
Completed
- Onchocerciasis
- Epilepsy
- bi-annual CDTI
-
Juba, Central, South SudanAmref Health Africa
Mar 1, 2023
Malaria, Anemia Trial in Cove (Bed nets)
Active, not recruiting
- Malaria
- Anemia
- Bed nets
-
Cove, BeninManfred Accrombessi
Aug 23, 2022
COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
-
Taizhou, Jiangsu, ChinaTaixing City center for Disease Control and Prevention
Oct 28, 2022
COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel
Active, not recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
-
Yancheng, Jiangsu, ChinaFuning Center for Disease Control and Prevention
Oct 28, 2022
Trichuriasis Trial in Kampala (IVM (200 µg/kg) + ALB (400 mg), ALB (400mg))
Not yet recruiting
- Trichuriasis
- IVM (200 µg/kg) + ALB (400 mg)
- ALB (400mg)
-
Kampala, UgandaVector Borne & Neglected Tropical Disease Control Division, Mini
Sep 7, 2023
Malaria,Falciparum Trial in Bagamoyo (ITENs + ITWS)
Recruiting
- Malaria,Falciparum
- ITENs + ITWS
-
Bagamoyo, TanzaniaVector Control Product Testing Unit Facility
Nov 19, 2021
Stress Urinary Incontinence Trial in United States (Vesair Balloon)
Terminated
- Stress Urinary Incontinence
- Vesair Balloon
-
Arlington Heights, Illinois
- +7 more
Jun 10, 2022
COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against
Completed
- COVID-19
- recombinant Ad5 vectored COVID-19 vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022
COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))
Completed
- COVID-19
- Recombinant SARS-CoV-2 Ad5 vectored vaccine
- Inactive SARS-CoV-2 vaccine (Vero cell)
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022
Developmental Language Disorder Trial in Stockholm (Grapholearn, Vector, Usual schooling)
Recruiting
- Developmental Language Disorder
- Grapholearn
- +2 more
-
Stockholm, SwedenKarolinska Institutet
Mar 16, 2022
Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL
Active, not recruiting
- Post-transplant Lymphoproliferative Disease
- Transplant-Related Hematologic Malignancy
- Autologous EBV-CTL transduced with vector SFG-CNA12
- +2 more
-
London, United Kingdom
- +1 more
Jan 19, 2022
COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel
Recruiting
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincal Center for Disease Control and Prevention
Jul 27, 2021
Malaria Trial in Rourkela (Malaria Camps)
Completed
- Malaria
- Malaria Camps
-
Rourkela, Odisha, IndiaCommunity Welfare Society Hospital
Dec 21, 2021
Malaria Trial in Washington, Manhica (Actellic CS)
Completed
- Malaria
- Actellic CS
-
Washington, District of Columbia
- +1 more
Sep 15, 2020
COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Aug 2, 2021
Anesthesia Trial in Milano (TI.VA algorithm: decision support system)
Completed
- Anesthesia
- TI.VA algorithm: decision support system
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jan 19, 2022
Arbovirus Infections Trial in Iquitos (transfluthrin, )
Completed
- Arbovirus Infections
- transfluthrin
- placebo
-
Iquitos, PeruUniversity of California, Davis
Mar 3, 2021
Malaria Trial in Windhoek (RACD, RAVC, rfMDA)
Completed
- Malaria
- RACD
- +2 more
-
Windhoek, NamibiaUniversity of Namibia Multidisciplinary Research Centre
Jul 15, 2020
COVID-19 Trial in Nanjing (Ad5-nCoV-IH, Ad5-nCoV-IM, CoronaVac)
Active, not recruiting
- COVID-19
- Ad5-nCoV-IH
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
Aug 12, 2022
HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )
Withdrawn
- HIV Infections
- VRC-HIVDNA016-00-VP
- +3 more
- (no location specified)
Oct 28, 2021
Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Bangkok (Case Management and Follow-up, Reactive focal mass
Recruiting
- Plasmodium Falciparum Malaria
- Plasmodium Vivax Malaria
- Case Management and Follow-up
- Reactive focal mass drug administration (rfMDA)
-
Bangkok, ThailandDivision of Vector Born Diseases, Ministry of Health
Mar 22, 2022
X-Linked Retinitis Pigmentosa Trial (rAAV2tYF-GRK1-hRPGRco)
Not yet recruiting
- X-Linked Retinitis Pigmentosa
- rAAV2tYF-GRK1-hRPGRco
- (no location specified)
May 19, 2021